摘要
间充质干细胞(mesenchymal stem cells,MSCs)是一种具有全能干细胞特点来源于中胚层发育的早期细胞,具有多向分化的潜能,在特定的诱导条件下可分化为多种细胞。目前,随着MSCs在治疗自身免疫性疾病方面研究日渐深入,越来越多的学者致力于MSCs对干眼的免疫治疗作用的研究。干眼发病率逐年增高,免疫相关性干眼治疗期长,且效果欠佳,影响人们生活质量,迫切需要开发新型治疗方法。因此本文主要就MSCs对干眼治疗方面做系统的综述。
Mesenchymal stem cells(MSCs) are multipotent stromal cells derived from the mesoderm that can differentiate into a variety of cell types.Recently,as the study of MSCs in the treatment of various autoimmune diseases is maturing,more and more researchers have advocated the immune function of MSCs and the treatment for dry eye.The rate of dry eye is higher.The duration of therapy in dry eye,especially immune related dry eye,is long,and the therapeutic effect is poor.Dry eye has affected people' s quality of life,so it is important to find new methods to treat it.This article reviews MSCs function in dry eye.
引文
[1]中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识(2013年)[J].中华眼科杂志,2013,49(1):73-75.DEPARTMENT OF OPHTHALMOLOGY,CHINESE ACADEMY OF MEDICAL SCIENCES.Global consensus on dry eye(2013)[J].Chin J Ophthalmol 2013 49(1):73-75.
[2]LI F,ZHAO SZ.Control of cross talk between angiogenesis and inflammation by mesenchymal stem cells for the treatment of ocular surface diseases[J].Stem Cells Int 2016 2016:7961816.
[3]STERN ME,SCHAUMBURG CS,PFLUGFELDER SC.Dry eye as a mucosal autoimmune disease[J].Int Rev Immunol,2013,32(1):19-41.
[4]STEVENSON W,CHAUHAN SK JJANA R.Dry eye disease:an immune-mediated ocular surface disorder[J].Arch Ophthalmol,2012,130(1):90-100.
[5]NGUYEN CQ,PECK AB.Unraveling the patho physio logy of Sjogren syndrome-associated dry eye disease[J].Ocul Surf 2009,7(1):11-27.
[6]ICHIM TE,HARMAN RJ,MIN WP,MINEV B,SOLANO F,RODRIGUEZ JP fit al.Autologous stromal vascular fraction cells:a tool for facilitating tolerance in rheumatic disease[J].Cell Immunol,2010 264(1):747.
[7]ZANNETTINO AC,PATON S,ARTHUR A JiHOR F JTESCU S,GIMBLE JM,et al.Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo[J].J Cell Physiol,2008,214(2):413-421.
[8]JO YY,LEE HJ,KOOK SY,CHOUNG HW,PARK JY,CHUNG JH,et al.Isolation and characterization of postnatal stem cells from human dental tissues[J].Tissue Eng 2007,13(4):767-773.
[9]RYAN JM,BARRY FP,MURPHY JM,MAH0N BP.Mesenchymal stem cells avoid allogeneic rejection[J].J Inflamm(Lond),2005,2:8.
[10]TSE WT,PENDLETON JD,BEYER WM,EGALKA MC,GUINAN EC.Suppression of allogeneic T-cell proliferation by human marrow stromal cells:implications in transplantation[J].Transplantation 2003,75(3):389-397.
[11]XU J,WANG D,LIU D,FAN Z ZHANG H,LIU O,et al.Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome[J].Blood 2012,120(15):3142-3151.
[12]VILLATORO AJ,FERNANDEZ V,CLAROS S,RICO-LLANOS GA,BECERRA J,ANDRADES JA.Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model[J].Biomed Res Int 2015 2015:527926.
[13]LEE MJ,KO AY,KO JH,LEE HJ,KIM MK,WEE WR fit at.Mesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye[J].Mol Ther 2015 23(1):139-146.
[14]De MIGUEL MP,FUENTES-JULIAN S,BLAZQUEZMARTINEZ A,PASCUAL CY,ALLER MA,ARIAS J,et at.Immunosuppressive properties of mesenchymal stem cells:advances and applications[J].Curr Mol Med,2012,12(5):574-591.
[15]YAO L,LI ZR,SU WR,LI YP,LIN ML ZHANG WX,et al.Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn[J].PLoS One 2012,7(2):e30842.
[16]SOLEYMANINEJADIAN E,PRAMANIK K,SAMADIAN E.Immunomodulatory properties of mesenchymal stem cells:cytokines and factors[J].Am J Reprod Immunol 2012 67(1):1-8.
[17]BASSIE J,DE ALMEIDA DC,MORAES-VIEIRA PM,CAMARA N 0.Exploring the role of soluble factors associated with immune regulatory properties of mesenchymal stem cells[J].Stem Cell Rev 2012 3(2):329-342.
[18]LI FR,WANG XG,DENG CY,QI H,REN LL,ZHOU HX.Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells[J].Clin Exp Immunol 2010,161(2):357-363.
[19]BEYAZYLDZ E,PNARLFA,BEYAZYLDZ O,HEKIMOGLU ER ACAR U,DEMIR MN et at.Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model[J].Stem Cells Int 2014 2014:250230.
[20]PFLUGFELDER SC,CORRALES RM,de PAIVA CS.T helper cytokines in dry eye disease[J].Exp Eye Res,2013,117:118-125.
[21]KHALILI S,LIU Y,KORNETE M,ROESCHER N,KODAMA S PETERSON A fit at.Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjogren's-like disease[J].PLoS One 2012,7(6):e38615.
[22]BURT RK,LOH Y,PEARCE W,BEOHAR N,BARR WG,CRAIG R,et al.Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases[J].JAMA,2008 299(8):925-936.
[23]ZAPPIA E,CASAZZA S,PEDEMONTE E,BENVENUTO F,BON ANN I I,GERDONI E,et al.Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy[J].Blood 2005,106(5):1755-1761.
[24]JO R GEN SEN C.Mesenchymal stem cells in arthritis:role of bone marrow microenvironment[J].Arthritis Res Ther 2010,12(4):135.
[25]LE BK,FR ASSO NI F,BALL L,LOC ATELLI F,R O ELO FS H,LEWIS I fit al.Mesenchymal stem cells for treatment of steroidresistant,Severe,acute graft-versus-host disease:a phase II study[J].Lancet 2008 371(9624):1579-1586.
[26]PARK SA,REILLY CM,W00D JA,CHUNG DJ,CARRADE DD,DEREMER SL,et al.Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland the gland of the third eyelid and the knee joint[J].Cytotherapy,2013,15(12):1498-1510.
[27]WENG J,HE C,LAI P,LUO C,GUO R,WU S fit al.Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease[J].Mol Ther,2012,20(12):2347-2354.
[28]HIRAYAMA M,KAWAKITA T,TSUBOTA K,SHIMMURA S.Challenges and strategies for regenerating the lacrimal gland[J].Ocul Surf 2016,14(2):135-143.
[29]MAY,XUY,XIAO Z JANG W,ZHANG C SONG E fit al.Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells[J].Stem Cells,2006 24(2):315-321.
[30]OGAWA Y,KUWANA M.Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation[J].Cornea 2003 22(7 Suppl):S19-27.
[31]SAITO T,KUANG JQ,BITTIRA B,AL4iHALDI A,CHIU RC.Xenotransplant cardiac chimera:immune tolerance of adult stem cells[J].Ann Thorac Surg 2002,74(1):19-24.
[32]SUN J,MANDAI M,KAMAO H,HASHIGUCHI T,SHIKAMURA M,KAWAMATA S,et al.Protective effects of human iPS-derived retinal pigmented epithelial cells in comparison with human mesenchymal stromal cells and human neural stem cells on the degenerating retina in rd1 mice[J].Stem Cells 2015 33(5):1543-1553.
